DrDoctor has secured £3 million in Series A Round investment to help expand the business and its platform used by healthcare teams across the country.
The platform supports over 8 million patients across 27 NHS Trusts with patient communications, helping to reduce missed appointments and administration costs.
The company said “the money will be used to hire across the business and add new functionality to DrDoctor’s patient communication platform, which transforms the way hospitals communicate with their patients.”
Found in 2012 by Tom Whicher, Rinesh Amin and Perran Pengelly, the company currently employs 60 staff and expects to add another 35 staff over the coming year as it expands its development and sales teams.
During the pandemic the company offered its Covid-19 Toolkit free of charge to any NHS Trust who wished to use it. The toolkit helped oversubscribed hospitals and clinics broadcast messages to their patients, ensuring appointments that had to be cancelled were rescheduled with minimal disruption. The company is now helping clients break the backlog in patient appointments by implementing recovery programmes built on remote assessments, patient-initiated follow-ups, and video consultations. The company developed its video consultation service in eight weeks during the pandemic to support its customers.
DrDoctor Co-Founder and CEO Tom Whicher said: “The team at DrDoctor have never been busier as we work to help our NHS Trusts break the backlog in care that has been created by the havoc of Covid-19. Having the backing of Ananda Impact Ventures and 24Haymarket will help us meet the tremendous demand that now exists for our services as care and patient communication goes digital. We are delighted to have their support.”
Paul Tselentis, CEO of 24Haymarket, said: “Even before Covid-19, there was a significant supply gap in the delivery of secondary healthcare services in the UK and this situation has been exacerbated by the Covid-19 outbreak and lock-down, placing an even greater imperative on the adoption of technologies that address this gap while improving patient outcomes.”
